This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2022 Apr 21;386(16):e43.

doi: 10.1056/NEJMc2200202.

Cardiovascular Events with Finerenone in CKD and Diabetes

Pei-Heng Kao¹, Li-Chuan Hsu²

Affiliations

PMID: 35443116
DOI: 10.1056/NEJMc2200202

Comment

Cardiovascular Events with Finerenone in CKD and Diabetes

Pei-Heng Kao et al. N Engl J Med. 2022.

. 2022 Apr 21;386(16):e43.

doi: 10.1056/NEJMc2200202.

Authors

Pei-Heng Kao¹, Li-Chuan Hsu²

Affiliations

¹ Chung-Ho Memorial Hospital, Kaohsiung, Taiwan.
² Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan taylor6174@gmail.com.

PMID: 35443116
DOI: 10.1056/NEJMc2200202

No abstract available

PubMed Disclaimer

Comment in

Cardiovascular Events with Finerenone in CKD and Diabetes. Reply.
Pitt B, Joseph A, Schloemer P. Pitt B, et al. N Engl J Med. 2022 Apr 21;386(16):e43. doi: 10.1056/NEJMc2200202. N Engl J Med. 2022. PMID: 35443119 No abstract available.

Comment on

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes.
Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; FIGARO-DKD Investigators. Pitt B, et al. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. N Engl J Med. 2021. PMID: 34449181 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information